Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

A compact whole-eye perfusion system to evaluate pharmacologic responses of outflow facility

Zhou, Enhua and Paolucci, Michael and Dryja, Ted and Manley, Ted and Rice, Dennis and Prasanna, Ganesh and Chen, Amy (2017) A compact whole-eye perfusion system to evaluate pharmacologic responses of outflow facility. Investigative Ophthalmology and Visual Science, 58 (7). pp. 2991-3003. ISSN 15525783

Abstract

PURPOSE. To discover novel therapies that lower IOP by increasing aqueous humor outflow facility, ex vivo ocular perfusion systems provide a valuable tool. However, currently available designs are limited by their throughput. Here we report the development of a compact, scalable perfusion system with improved throughput and its validation using bovine and porcine eyes. METHODS. At a fixed IOP of 6 mm Hg, flow rate was measured by flow sensors. We validated the system by measuring the outflow responses to Y-39983 (a Rho kinase inhibitor), endothelin-1 (ET-1), ambrisentan (an antagonist for endothelin receptor A [ETA ]), sphigosine-1-phosphate (S1P), JTE-013 (antagonist for S1P receptor 2 [S1P2]), S-nitroso-N-acetylpenicill-amine (SNAP, a nitric oxide [NO] donor), and 3-Morpholino-sydnonimine (SIN-1, another NO donor). RESULTS. The instrument design enabled simultaneous measurements of 20 eyes with a footprint of 1 m2. Relative to vehicle control, Y-39983 increased outflow by up to 31% in calf eyes. On the contrary, ET-1 decreased outflow by up to 79%, a response that could be blocked by pretreatment with ambrisentan, indicating a role for ETA receptors. Interestingly, the effect of ET-1 was also inhibited by up to 70% to 80% by pretreatment with NO donors, SNAP and SIN-1. In addition to testing in calf eyes, similar effects of ET-1 and ambrisentan were observed in adult bovine and porcine eyes. CONCLUSIONS. The compact eye perfusion platform provides an opportunity to efficiently identify compounds that influence outflow facility and may lead to the discovery of new glaucoma therapies.

Item Type: Article
Keywords: Conventional outflow facility Drug discovery Flow sensor High throughput
Date Deposited: 22 Jul 2017 00:45
Last Modified: 25 Jan 2019 00:45
URI: https://oak.novartis.com/id/eprint/31270

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.